最近発症した1型糖尿病患者の38 kDのインスリン分泌粒子のタンパク質に対するT細胞の反応性
関連する実験動画
Updated: Jul 19, 2026
08:32
Extraction of Tissue Antigens for Functional Assays
Published on: September 10, 2012
B O Roep1, A A Kallan, W L Hazenbos
1Department of Immunohaematology and Blood Bank, University Hospital Leiden, The Netherlands.
Lancet (London, England)
|June 15, 1991
まとめ
新たに発症した1型糖尿病のほとんどの子供のT細胞は,小島細胞抗原に反応して増殖します. この自己免疫性T細胞応答は,増殖アッセイで検出され,1型糖尿病の診断と免疫療法に役立ちます.
科学分野:
- 免疫学 免疫学とは
- エンドクリノロジー エンドクリノロジー
- 自己免疫疾患 自己免疫疾患
背景:
- 1型糖尿病は,T細胞を含む自己免疫疾患である.
- 分泌粒子の38kDaの小島細胞抗原が潜在的な標的である.
- T細胞の反応を理解することは,病気の管理に極めて重要です.
研究 の 目的:
- 新たに発症した1型糖尿病における小島細胞抗原に対するT細胞反応性の有病率を調査する.
- T細胞増殖アッセイが患者の自己免疫反応を検出できるかどうかを判断する.
- 特定のT細胞応答を特定する診断および治療の可能性を探求する.
主な方法:
- 新たに発症した1型糖尿病の19人の子供と16人の健康な対照群からインビトロでT細胞系を生成した.
- ネズミのベータ細胞腫瘍のサブセルラー分子を含んだ細胞をインキュベートした.
- 島根細胞抗原製剤への反応としてT細胞の増殖を評価した.
主要な成果:
- 患者のT細胞系のうち74%が陽性増殖を示し,対照群では13%であった (p = 3 x 10 ((-4)).
- 38 kDa抗原に対するT細胞の反応性は,患者と1人の島細胞自己抗体陽性非糖尿病被験者に特異的であった.
- 反応性のあるT細胞系は,糖尿病のない2人の小島細胞自己抗体陽性個体でも発見されました.
結論:
- 進行中の自己免疫性T細胞応答は,タイプ1糖尿病の発症時に検出されます.
- 特定の抗原を標的としたT細胞増殖アッセイは,1型糖尿病の診断に有望である.
- これらのT細胞の反応を特定することで,糖尿病を予防する特定の免疫療法への道を開くことができます.
関連する概念動画
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...